AKT1 and non-small cell lung carcinoma: Treatment with resveratrol alone or in combination with rapamycin efficiently inhibited cell growth by inducing growth stop by targeting Akt activation and preventing mTORC1 signaling cascade phosphorylation-activation [31] Consistently, resveratrol was shown to decrease cellular levels of PI3K and p-Akt in NSCLC [12].